Search

Your search keyword '"Hicks R.J."' showing total 119 results

Search Constraints

Start Over You searched for: Author "Hicks R.J." Remove constraint Author: "Hicks R.J."
119 results on '"Hicks R.J."'

Search Results

2. Joint EANM/SNMMI procedure guideline for the use of (177)Lu-labeled PSMA-targeted radioligand-therapy ((177)Lu-PSMA-RLT).

6. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers

7. Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region.

8. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

9. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours

10. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.

11. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms

13. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

14. Peptide Receptor Radionuclide Therapy (PRRT) during the COVID-19 pandemic: are there any concerns?

15. 1160O An international open-label study on safety and efficacy of 177Lu-satoreotide tetraxetan in somatostatin receptor positive neuroendocrine tumours (NETs): An interim analysis

16. First in Human Study of In-vivo Imaging of Ex-Vivo Labelled CAR T Cells with Dual PET-MR

17. Clinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC)

20. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma

21. Effect of sorption on the biodegradation of quinoline

23. Consensus on molecular imaging and theranostics in prostate cancer

24. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

25. Unmet needs in the management of neuroendocrine tumours (NETs): A global survey of patients, patient advocates and healthcare professionals

26. Circulating tumour DNA analysis predicts relapse following resection in stage II and III melanoma

27. Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma

29. Hepatic functional imaging and genomics to predict irinotecan pharmacokinetics and pharmacodynamics: The PREDICT IR study

30. Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA

33. Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tubingen, Germany

34. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model.

35. Initial survival outcomes for the AGITG GAP study-a phase II study of perioperative <<<<A-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC).

36. Initial experience with gallium-68 DOTA-Octreotate PET/CT and peptide receptor radionuclide therapy for pediatric patients with refractory metastatic neuroblastoma.

42. The motivations and methodology for high-throughput PET imaging of small animals in cancer research.

43. The impact of PET-CT in suspected recurrent ovarian cancer: A prospective multi-centre study as part of the Australian PET Data Collection Project.

44. Intraperitoneal distribution imaging in ovarian cancer patients.

50. 2895

Catalog

Books, media, physical & digital resources